PLX5622

TargetMol
Product Code: TAR-T7100
Supplier: TargetMol
CodeSizePrice
TAR-T7100-1mL1 mL * 10 mM (in DMSO)£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7100-5mg5mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7100-10mg10mg£200.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7100-25mg25mg£331.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7100-50mg50mg£502.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7100-100mg100mg£592.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7100-500mg500mg£1,179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
PLX-5622 is a highly selective brain penetrant and oral active CSF1R inhibitor.
CAS:
1303420-67-8
Formula:
C21H19F2N5O
Molecular Weight:
395.414
Pathway:
Tyrosine Kinase/Adaptors
Purity:
0.9989
SMILES:
COc1ncc(F)cc1CNc1ccc(Cc2c[nH]c3ncc(C)cc23)c(F)n1
Target:
c-Fms; CSF-1R

References

Rosin JM, Vora SR, Kurrasch DM.Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour[J].Brain Behav Immun. 2018 Oct;73:682-697. Yu Z, Fang X, Liu W, et al. Microglia Regulate Blood?Brain Barrier Integrity via MiR?126a?5p/MMP9 Axis during Inflammatory Demyelination. Advanced Science. 2022: 2105442 Li C, Wu H, Na H S T, et al. Neuronal-Microglial Liver X receptor ? Activating Decrease Neuroinflammation and Chronic Stress-induced Depression-Related Behavior in Mice. Brain Research. 2022: 148112. Spangenberg E, Severson PL, Hohsfield LA,et al.Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model[J].Nat Commun. 2019 Aug 21;10(1):3758.